U.S. Sees 800% Surge in Congenital Syphilis Cases Amid Drug Shortage
The United States has experienced an 800% increase in babies born with congenital syphilis between 2012 and 2024. Public health officials consider congenital syphilis a "never event" as it is preventable through an injectable form of penicillin administered to pregnant individuals. This alarming rise occurs concurrently with a reported shortage of the crucial preventive drug since last year, intensifying concerns for maternal and child health.
Congenital syphilis, a severe condition that can afflict newborns, has surged dramatically in the United States. Between 2012 and 2024, the nation recorded an 800% increase in babies born with this preventable disease. Infants affected by congenital syphilis may suffer from dire consequences, including bone deformities, brain damage, blindness, and deafness.
Public health officials emphasize that congenital syphilis should be a "never event," given its known preventability. The infection can be averted if a pregnant individual receives an injectable form of penicillin. This treatment is highly effective in preventing the transmission of the infection from mother to child.
Despite the existence of effective preventive measures, the incidence of congenital syphilis continues to climb. Further exacerbating this public health challenge, a critical shortage of the specific injectable penicillin required for prevention has been reported since last year. This dual crisis of rising cases and drug scarcity poses significant concerns for maternal and child health across the country.
(Source: STAT News)
